Good morning, everyone. Thank you for joining CSL's results presentation for the first half of the 2026 financial year. I'm Mark Dehring, CSL's Head of Investor Relations. Please note, this briefing ...

THE business mastermind at CSL will walk away with one of corporate Australia's most lucrative farewell packages. Brian McNamee, regarded as one of the nation's best chief executives, will leave with ...

That’s the scale of the upheaval inside Australia’s global pharma, with the bloody sacking of its chief executive just as the US-born boss was about to release the company’s first half accounts. The ...

Let's see if analysts see value in these popular shares this month. This energy producer's shares are fully valued according to analysts at Morgans. Given its free cash flow outlook and difficult to ...

The global biotechnology company announced minutes before the market closed on Tuesday that Mr McKenzie would be immediately replaced by Gordon Naylor, a current CSL director who has held a number of ...

Welcome to my ChartWatch Daily ASX Scans series. Here, I present scan lists based on my trend following technical analysis methodology. My goal is to alert you to the best uptrends and downtrends on ...

The ASX 200 index had its best day since April, rising 1.9 per cent to 8870.1 points. US investors fuelled a Dow rally on Friday, pushing the index past 50,000 points for the first time and marking ...

This afternoon, CSL Ltd (ASX: CSL) announced the retirement of CEO Dr Paul McKenzie and the appointment of Gordon Naylor as interim CEO and managing director. The leadership change comes as CSL ...